Also trades as: NYMX (NASDAQ) · $vol 0M
NYMXF OTC
Nymox Pharmaceutical Corporation
1W: -68.0%
1M: +15900.0%
3M: -73.3%
YTD: -31.3%
1Y: -44.4%
3Y: -93.9%
5Y: -98.4%
$0.03
+0.00 (+0.00%)
Weekly Expected Move ±4945.7%
$-3
$-2
$0
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$654K
+4.3% ▲
5Y CAGR: -36.0%
Total Liabilities
$7M
+95.5% ▲
5Y CAGR: +29.5%
Shareholders Equity
-$7M
-113.5% ▼
Cash & Investments
$74K
+5.7% ▲
5Y CAGR: -57.3%
Total Debt
$0
-100.0% ▼
Net Debt
-$74K
-110.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4M | $830K | $1M | $70K | $74K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $4M | $830K | $1M | $70K | $74K |
| Net Receivables | $20K | $13K | $10K | $11K | $27K |
| Inventory | $34K | $34K | $0 | $0 | $0 |
| Other Current Assets | $200K | $132K | $0 | $0 | $0 |
| Total Current Assets | $4M | $1M | $1M | $625K | $653K |
| Property, Plant & Equip. | $450K | $406K | $168K | $2K | $1K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $589K | $589K | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $1M | $995K | $168K | $2K | $1K |
| Total Assets | $5M | $2M | $2M | $627K | $654K |
| — Liabilities — | |||||
| Accounts Payable | $1M | $1M | $2M | $3M | $4M |
| Short-Term Debt | $0 | $0 | $0 | $750K | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $124K | $23K | $5K | $0 | $3M |
| Total Current Liabilities | $2M | $2M | $2M | $4M | $7M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $368K | $163K | $0 | $0 | $0 |
| Total Liabilities | $2M | $2M | $2M | $4M | $7M |
| — Equity — | |||||
| Common Stock | $152M | $165M | $172M | $174M | $178M |
| Retained Earnings | -$180M | -$193M | -$199M | -$208M | -$212M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $3M | $83K | -$482K | -$3M | -$7M |
| Total Liabilities & Equity | $5M | $2M | $2M | $627K | $654K |
| — Key Metrics — | |||||
| Total Debt | $426K | $391K | $173K | $750K | $0 |
| Net Debt | -$3M | -$439K | -$1M | $680K | -$74K |
| Total Investments | $589K | $589K | $0 | $0 | $0 |